Prevention of contrast-induced nephropathy by N-acetylcysteine in critically ill patients: Different definitions, different results

Journal of Critical Care

Volumn 28, Issue 5, 2013, Pages 701-709

  Chousterman, Benjamin G ^a   Bouadma, Lila ^b   Moutereau, Stephane ^a   Loric, Sylvain ^a   Alvarez Gonzalez, Antonio ^a   Mekontso Dessap, Armand ^a   Laissy, Jean Pierre ^b   Rahmouni, Alain ^a   Katsahian, Sandrine ^a   Brochard, Laurent ^a,c   Schortgen, Frédérique ^a  

^a HENRI MONDOR HOSPITAL   (France)

^b BICHAT HOSPITAL   (France)

^c GENEVA UNIVERSITY HOSPITALS   (Switzerland)

Author keywords

Acute kidney injury; Contrast media; Cystatin C; ICU; N acetycysteine

Indexed keywords

ACETYLCYSTEINE; ANGIOTENSIN RECEPTOR ANTAGONIST; CALCIUM CHANNEL BLOCKING AGENT; CONTRAST MEDIUM; CREATININE; CYSTATIN C; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; IOHEXOL; SODIUM CHLORIDE;

ADULT; AGED; ANGIOGRAPHY; ARTICLE; CHEMOPROPHYLAXIS; COHORT ANALYSIS; CONTRAST ENHANCEMENT; CONTRAST INDUCED NEPHROPATHY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CREATININE BLOOD LEVEL; CRITICALLY ILL PATIENT; DRUG EFFICACY; DRUG EXPOSURE; ENTERAL DRUG ADMINISTRATION; GLOMERULUS FILTRATION RATE; HUMAN; INCIDENCE; INTENSIVE CARE UNIT; MAJOR CLINICAL STUDY; PROSPECTIVE STUDY; RISK FACTOR;

ACUTE KIDNEY INJURY; CONTRAST MEDIA; CYSTATIN C; ICU; N-ACETYCYSTEINE;

ACETYLCYSTEINE; ADULT; AGED; CONTRAST MEDIA; CREATININE; CRITICAL ILLNESS; CYSTATIN C; FEMALE; FREE RADICAL SCAVENGERS; HUMANS; IOHEXOL; KIDNEY DISEASES; KIDNEY FUNCTION TESTS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; TREATMENT OUTCOME;

EID: 84883551524     PISSN: 08839441     EISSN: 15578615     Source Type: Journal    
DOI: 10.1016/j.jcrc.2013.03.007     Document Type: Article

References (56)

1. Nash K., Hafeez A., Hou S. Hospital-acquired renal insufficiency. Am J Kidney Dis 2002, 39(5):930-936.
2. Hoste E.A., Doom S., De Waele J., et al. Epidemiology of contrast-associated acute kidney injury in ICU patients: a retrospective cohort analysis. Intensive Care Med 2011, 37(12):1921-1931.
3. Levy E.M., Viscoli C.M., Horwitz R.I. The effect of acute renal failure on mortality. A cohort analysis. JAMA 1996, 275(19):1489-1494.
4. Mehran R., Aymong E.D., Nikolsky E., et al. A simple risk score for prediction of contrast-induced nephropathy after percutaneous coronary intervention: development and initial validation. J Am Coll Cardiol 2004, 44(7):1393-1399.
5. Haveman J.W., Gansevoort R.T., Bongaerts A.H., et al. Low incidence of nephropathy in surgical ICU patients receiving intravenous contrast: a retrospective analysis. Intensive Care Med 2006, 32(8):1199-1205. Epub 2006 Jun 1192.
6. Hipp A., Desai S., Lopez C., et al. The incidence of contrast-induced nephropathy in trauma patients. Eur J Emerg Med 2008, 15(3):134-139.
7. Huber W., Jeschke B., Page M., et al. Reduced incidence of radiocontrast-induced nephropathy in ICU patients under theophylline prophylaxis: a prospective comparison to series of patients at similar risk. Intensive Care Med 2001, 27(7):1200-1209.
8. Lakhal K., Ehrmann S., Chaari A., et al. Acute Kidney Injury Network definition of contrast-induced nephropathy in the critically ill: incidence and outcome. J Crit Care 2011, 26(6):593-599.
9. Ehrmann S., Badin J., Savath L., et al. Acute kidney injury in the critically ill: is iodinated contrast medium really harmful?. Crit Care Med 2013, [Epub ahead of print].
10. Bellomo R., Ronco C., Kellum J.A., et al. Acute renal failure-definition, outcome measures, animal models, fluid therapy and information technology needs: the Second International Consensus Conference of the Acute Dialysis Quality Initiative (ADQI) Group. Crit Care 2004, 8(4):R204-212.
11. Mehta R.L., Kellum J.A., Shah S.V., et al. Acute Kidney Injury Network: report of an initiative to improve outcomes in acute kidney injury. Crit Care 2007, 11(2):R31.
12. Macedo E., Malhotra R., Claure-Del Granado R., et al. Defining urine output criterion for acute kidney injury in critically ill patients. Nephrol Dial Transplant 2010, 26(2):509-515.
13. Wlodzimirow K.A., Abu-Hanna A., Slabbekoorn M., et al. A comparison of RIFLE with and without urine output criteria for acute kidney injury in critically ills. Crit Care 2012, 16(5):R200.
14. Barrett B.J., Parfrey P.S. Clinical practice. Preventing nephropathy induced by contrast medium. N Engl J Med 2006, 354(4):379-386.
15. Ng C.S., Shaw A.D., Bell C.S., et al. Effect of IV contrast medium on renal function in oncologic patients undergoing CT in ICU. AJR Am J Roentgenol 2010, 195(2):414-422.
16. Tepel M., van der Giet M., Schwarzfeld C., et al. Prevention of radiographic-contrast-agent-induced reductions in renal function by acetylcysteine. N Engl J Med 2000, 343(3):180-184.
17. Bagshaw S.M., McAlister F.A., Manns B.J., et al. Acetylcysteine in the prevention of contrast-induced nephropathy: a case study of the pitfalls in the evolution of evidence. Arch Intern Med 2006, 166(2):161-166.
18. Biondi-Zoccai G.G., Lotrionte M., Abbate A., et al. Compliance with QUOROM and quality of reporting of overlapping meta-analyses on the role of acetylcysteine in the prevention of contrast associated nephropathy: case study. BMJ 2006, 332(7535):202-209.
19. Hoffmann U., Fischereder M., Kruger B., et al. The value of N-acetylcysteine in the prevention of radiocontrast agent-induced nephropathy seems questionable. J Am Soc Nephrol 2004, 15(2):407-410.
20. Gonzales D.A., Norsworthy K.J., Kern S.J., et al. A meta-analysis of N-acetylcysteine in contrast-induced nephrotoxicity: unsupervised clustering to resolve heterogeneity. BMC Med 2007, 5:32.
21. Moran S.M., Myers B.D. Course of acute renal failure studied by a model of creatinine kinetics. Kidney Int 1985, 27(6):928-937.
22. Waikar S.S., Bonventre J.V. Creatinine kinetics and the definition of acute kidney injury. J Am Soc Nephrol 2009, 20(3):672-679.
23. Brown J.R., McCullough P.A., Splaine M.E., et al. How do centres begin the process to prevent contrast-induced acute kidney injury: a report from a new regional collaborative. Bmj Qual Saf 2012, 21(1):54-62.
24. Gurm H.S., Smith D.E., Berwanger O., et al. Contemporary use and effectiveness of N-acetylcysteine in preventing contrast-induced nephropathy among patients undergoing percutaneous coronary intervention. JACC Cardiovasc Interv 2012, 5(1):98-104.
25. Solomon R., Werner C., Mann D., et al. Effects of saline, mannitol, and furosemide to prevent acute decreases in renal function induced by radiocontrast agents. N Engl J Med 1994, 331(21):1416-1420.
26. Le Gall J.R., Lemeshow S., Saulnier F. A new Simplified Acute Physiology Score (SAPS II) based on a European/North American multicenter study. JAMA 1993, 270(24):2957-2963.
27. Le Gall J.R., Klar J., Lemeshow S., et al. The Logistic Organ Dysfunction system. A new way to assess organ dysfunction in the intensive care unit. ICU Scoring Group. JAMA 1996, 276(10):802-810.
28. Levey A.S., Bosch J.P., Lewis J.B., et al. A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group. Ann Intern Med 1999, 130(6):461-470.
29. Cely C.M., Schein R.M., Quartin A.A. Risk of contrast induced nephropathy in the critically ill: a prospective, case matched study. Crit Care 2012, 16(2):R67.
30. Nin N., Lombardi R., Frutos-Vivar F., et al. Early and small changes in serum creatinine concentrations are associated with mortality in mechanically ventilated patients. Shock 2010, 34(2):109-116.
31. Schortgen F., Brochard L. Identifying a biomarker for acute kidney injury: an illusory quest?. Am J Respir Crit Care Med 2011, 183(7):838-840.
32. Lassnigg A., Schmidlin D., Mouhieddine M., et al. Minimal changes of serum creatinine predict prognosis in patients after cardiothoracic surgery: a prospective cohort study. J Am Soc Nephrol 2004, 15(6):1597-1605.
33. Ducharme M.P., Smythe M., Strohs G. Drug-induced alterations in serum creatinine concentrations. Ann Pharmacother 1993, 27(5):622-633.
34. Han S.S., Kang K.J., Kwon S.J., et al. Additional role of urine output criterion in defining acute kidney injury. Nephrol Dial Transplant 2012, 27(1):161-165.
35. Rickli H., Benou K., Ammann P., et al. Time course of serial cystatin C levels in comparison with serum creatinine after application of radiocontrast media. Clin Nephrol 2004, 61(2):98-102.
36. Diaz-Sandoval L.J., Kosowsky B.D., Losordo D.W. Acetylcysteine to prevent angiography-related renal tissue injury (the APART trial). Am J Cardiol 2002, 89(3):356-358.
37. Shyu K.G., Cheng J.J., Kuan P. Acetylcysteine protects against acute renal damage in patients with abnormal renal function undergoing a coronary procedure. J Am Coll Cardiol 2002, 40(8):1383-1388.
38. Herget-Rosenthal S., Marggraf G., Husing J., et al. Early detection of acute renal failure by serum cystatin C. Kidney Int 2004, 66(3):1115-1122.
39. Poletti P.A., Saudan P., Platon A., et al. I.v. N-acetylcysteine and emergency CT: use of serum creatinine and cystatin C as markers of radiocontrast nephrotoxicity. AJR Am J Roentgenol 2007, 189(3):687-692.
40. Lognard M., Cavalier E., Chapelle J.P., et al. Acetylcysteine and enzymatic creatinine: beware of laboratory artefact!. Intensive Care Med 2008, 34(5):973-974.
41. Alioglu E., Saygi S., Turk U., et al. N-acetylcysteine in preventing contrast-induced nephropathy assessed by Cystatin C. Cardiovasc Ther 2011, 29:1755-5922.
42. Droppa M., Desch S., Blase P., et al. Impact of N-acetylcysteine on contrast-induced nephropathy defined by cystatin C in patients with ST-elevation myocardial infarction undergoing primary angioplasty. Clin Res Cardiol 2011, 100(11):1037-1043.
43. Jaffery Z., Verma A., White C.J., et al. A randomized trial of intravenous N-acetylcysteine to prevent contrast induced nephropathy in acute coronary syndromes. Catheter Cardiovasc Interv 2012, 79(6):921-926.
44. Kim B.J., Sung K.C., Kim B.S., et al. Effect of N-acetylcysteine on cystatin C-based renal function after elective coronary angiography (ENABLE Study): a prospective, randomized trial. Int J Cardiol 2010, 138(3):239-245.
45. Merkle M., Sauter M., Argirov M., et al. Cystatin C and creatinine as markers for radiocontrast-induced nephropathy in patients treated with N-acetylcysteine. Ren Failure 2010, 32(1):85-90.
46. Mainra R., Gallo K., Moist L. Effect of N-acetylcysteine on renal function in patients with chronic kidney disease. Nephrology (Carlton) 2007, 12(5):510-513.
47. Moist L., Sontrop J.M., Gallo K., et al. Effect of N-acetylcysteine on serum creatinine and kidney function: results of a randomized controlled trial. Am 2010, 56(4):643-650.
48. Rehman T., Fought J., Solomon R. N-acetylcysteine effect on serum creatinine and cystatin C levels in CKD patients. Clin J Am Soc Nephrol 2008, 3(6):1610-1614. Epub 2008 Jul 1630.
49. Haase M., Haase-Fielitz A., Ratnaike S., et al. N-Acetylcysteine does not artifactually lower plasma creatinine concentration. Nephrol Dial Transplant 2008, 23(5):1581-1587.
50. Ristikankare A., Kuitunen T., Kuitunen A., et al. Lack of renoprotective effect of i.v. N-acetylcysteine in patients with chronic renal failure undergoing cardiac surgery. Br J Anaesth 2006, 97(5):611-616.
51. Le Bricon T., Leblanc I., Benlakehal M., et al. Evaluation of renal function in intensive care: plasma cystatin C vs. creatinine and derived glomerular filtration rate estimates. Clin Chem Lab Med 2005, 43(9):953-957.
52. Valette X., du Cheyron D. Contrast "induced" versus "associated" acute kidney injury: take care with the definition. Intensive 2012, 38(3):527.
53. Lynch R.M., Robertson R. Anaphylactoid reactions to intravenous N-acetylcysteine: a prospective case controlled study. Accid Emerg Nurs 2004, 12(1):10-15.
54. Morris P.E., Papadakos P., Russell J.A., et al. A double-blind placebo-controlled study to evaluate the safety and efficacy of L-2-oxothiazolidine-4-carboxylic acid in the treatment of patients with acute respiratory distress syndrome. Crit Care Med 2008, 36(3):782-788.
55. Peake S.L., Moran J.L., Leppard P.I. N-acetyl-L-cysteine depresses cardiac performance in patients with septic shock. Crit Care Med 1996, 24(8):1302-1310.
56. Wijeysundera D.N., Karkouti K., Rao V., et al. N-acetylcysteine is associated with increased blood loss and blood product utilization during cardiac surgery. Crit Care Med 2009, 37(6):1929-1934.